Skip to main content
Federal Lobbying Data · Senate LDA Filings · Updated Quarterly
LobbySpend

Amgen Inc

Pharmaceutical & Health Products · Lobbying Client

C
Influence Score
56/100
Moderate Influence
$23.1M
Total Lobby Spend
4
Policy Issues
15
Lobbyists
5
Revolving Door

Amgen Inc reported $23.1 million in federal lobbying expenditures (2020-2024) as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Dept of State
Dept of Justice
Office of Management & Budget
Dept of Education
National Science Foundation

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2024 Oct-DecCornerstone Government Affairs
MEDPHAHCR+1
1$998K
2024 Jul-SepPeck Madigan Jones
MEDPHAHCR+1
4$887K
2024 Apr-JunAkin Gump Strauss Hauer & Feld
PHAGOVMED+1
1$950K
2024 Jan-MarCornerstone Government Affairs
PHAHCRMED
3$856K
2023 Oct-DecJones Day
HCRMEDGOV
3$764K
2023 Jul-SepCapitol Counsel
HCRPHAMED+1
3$823K
2023 Apr-JunVenable LLP
HCRMEDPHA+1
4$931K
2023 Jan-MarSubject Matter
GOVPHAHCR
3$806K

Amgen Inc Lobbying FAQ

Amgen Inc has spent $23.1M on federal lobbying across 4 policy areas. This includes spending on registered lobbyists and direct government contacts.

Amgen Inc lobbies on 4 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Government Issues. These disclosures are filed quarterly with the Senate Office of Public Records.

Amgen Inc has an Influence Score of 56/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

Amgen Inc employs 15 registered lobbyists, of whom 5 have revolving door connections, meaning they previously held government positions before becoming lobbyists.

Amgen Inc has contacted 5 government entities as part of their lobbying activities, including Dept of State, Dept of Justice, Office of Management & Budget.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.